nodes	percent_of_prediction	percent_of_DWPC	metapath
Rufinamide—ALB—Liothyronine—hypothyroidism	0.213	0.304	CbGbCtD
Rufinamide—ALB—Levothyroxine—hypothyroidism	0.213	0.304	CbGbCtD
Rufinamide—ALB—Liotrix—hypothyroidism	0.208	0.297	CbGbCtD
Rufinamide—CYP3A4—Levothyroxine—hypothyroidism	0.0666	0.0953	CbGbCtD
Rufinamide—SCN8A—cerebellar cortex—hypothyroidism	0.032	0.152	CbGeAlD
Rufinamide—SCN11A—nerve—hypothyroidism	0.0155	0.0737	CbGeAlD
Rufinamide—SCN8A—nerve—hypothyroidism	0.0117	0.0559	CbGeAlD
Rufinamide—SCN10A—nerve—hypothyroidism	0.00786	0.0374	CbGeAlD
Rufinamide—GRM5—blood—hypothyroidism	0.00578	0.0275	CbGeAlD
Rufinamide—CYP2E1—urine—hypothyroidism	0.0049	0.0233	CbGeAlD
Rufinamide—SCN7A—heart—hypothyroidism	0.00489	0.0233	CbGeAlD
Rufinamide—GRM5—testis—hypothyroidism	0.00478	0.0227	CbGeAlD
Rufinamide—SCN7A—cardiovascular system—hypothyroidism	0.00462	0.022	CbGeAlD
Rufinamide—GRM5—cerebellum—hypothyroidism	0.00442	0.021	CbGeAlD
Rufinamide—CYP3A4—urine—hypothyroidism	0.00394	0.0188	CbGeAlD
Rufinamide—Increased appetite—Levothyroxine—hypothyroidism	0.00386	0.0459	CcSEcCtD
Rufinamide—Increased appetite—Dextrothyroxine—hypothyroidism	0.00386	0.0459	CcSEcCtD
Rufinamide—SCN7A—adrenal gland—hypothyroidism	0.00365	0.0174	CbGeAlD
Rufinamide—SCN7A—thyroid gland—hypothyroidism	0.00352	0.0168	CbGeAlD
Rufinamide—SCN4A—heart—hypothyroidism	0.00342	0.0163	CbGeAlD
Rufinamide—SCN7A—female gonad—hypothyroidism	0.00341	0.0162	CbGeAlD
Rufinamide—SCN9A—pituitary gland—hypothyroidism	0.0032	0.0152	CbGeAlD
Rufinamide—CES1—heart—hypothyroidism	0.00305	0.0145	CbGeAlD
Rufinamide—SCN7A—testis—hypothyroidism	0.00302	0.0144	CbGeAlD
Rufinamide—CES1—cardiovascular system—hypothyroidism	0.00288	0.0137	CbGeAlD
Rufinamide—SCN9A—adrenal gland—hypothyroidism	0.00286	0.0136	CbGeAlD
Rufinamide—SCN4A—pituitary gland—hypothyroidism	0.00286	0.0136	CbGeAlD
Rufinamide—SCN7A—liver—hypothyroidism	0.00286	0.0136	CbGeAlD
Rufinamide—Increased appetite—Liotrix—hypothyroidism	0.00284	0.0338	CcSEcCtD
Rufinamide—Weight decreased—Levothyroxine—hypothyroidism	0.00284	0.0337	CcSEcCtD
Rufinamide—Weight decreased—Dextrothyroxine—hypothyroidism	0.00284	0.0337	CcSEcCtD
Rufinamide—SCN8A—testis—hypothyroidism	0.00269	0.0128	CbGeAlD
Rufinamide—SCN3A—heart—hypothyroidism	0.00266	0.0126	CbGeAlD
Rufinamide—SCN5A—heart—hypothyroidism	0.00265	0.0126	CbGeAlD
Rufinamide—SCN4A—adrenal gland—hypothyroidism	0.00255	0.0121	CbGeAlD
Rufinamide—SCN2A—pituitary gland—hypothyroidism	0.00253	0.012	CbGeAlD
Rufinamide—SCN5A—cardiovascular system—hypothyroidism	0.0025	0.0119	CbGeAlD
Rufinamide—SCN8A—cerebellum—hypothyroidism	0.00249	0.0118	CbGeAlD
Rufinamide—SCN4A—thyroid gland—hypothyroidism	0.00246	0.0117	CbGeAlD
Rufinamide—SCN10A—pituitary gland—hypothyroidism	0.00244	0.0116	CbGeAlD
Rufinamide—SCN9A—testis—hypothyroidism	0.00237	0.0112	CbGeAlD
Rufinamide—CES1—adrenal gland—hypothyroidism	0.00228	0.0108	CbGeAlD
Rufinamide—CES1—blood—hypothyroidism	0.00228	0.0108	CbGeAlD
Rufinamide—SCN2A—blood—hypothyroidism	0.00226	0.0107	CbGeAlD
Rufinamide—SCN3A—pituitary gland—hypothyroidism	0.00222	0.0106	CbGeAlD
Rufinamide—Bronchitis—Liotrix—hypothyroidism	0.00222	0.0264	CcSEcCtD
Rufinamide—CES1—thyroid gland—hypothyroidism	0.0022	0.0105	CbGeAlD
Rufinamide—SCN10A—blood—hypothyroidism	0.00218	0.0104	CbGeAlD
Rufinamide—CES1—female gonad—hypothyroidism	0.00213	0.0101	CbGeAlD
Rufinamide—ALB—heart—hypothyroidism	0.00212	0.0101	CbGeAlD
Rufinamide—SCN4A—testis—hypothyroidism	0.00211	0.01	CbGeAlD
Rufinamide—Weight decreased—Liotrix—hypothyroidism	0.00209	0.0248	CcSEcCtD
Rufinamide—Tremor—Levothyroxine—hypothyroidism	0.00205	0.0243	CcSEcCtD
Rufinamide—Tremor—Dextrothyroxine—hypothyroidism	0.00205	0.0243	CcSEcCtD
Rufinamide—Agitation—Levothyroxine—hypothyroidism	0.00201	0.0239	CcSEcCtD
Rufinamide—Agitation—Dextrothyroxine—hypothyroidism	0.00201	0.0239	CcSEcCtD
Rufinamide—SCN3A—adrenal gland—hypothyroidism	0.00198	0.00944	CbGeAlD
Rufinamide—SCN3A—blood—hypothyroidism	0.00198	0.00944	CbGeAlD
Rufinamide—SCN5A—blood—hypothyroidism	0.00198	0.00941	CbGeAlD
Rufinamide—SCN3A—thyroid gland—hypothyroidism	0.00192	0.00911	CbGeAlD
Rufinamide—Convulsion—Levothyroxine—hypothyroidism	0.00189	0.0225	CcSEcCtD
Rufinamide—Convulsion—Dextrothyroxine—hypothyroidism	0.00189	0.0225	CcSEcCtD
Rufinamide—CES1—testis—hypothyroidism	0.00188	0.00896	CbGeAlD
Rufinamide—SCN1A—cerebellum—hypothyroidism	0.00188	0.00894	CbGeAlD
Rufinamide—Anxiety—Dextrothyroxine—hypothyroidism	0.00185	0.022	CcSEcCtD
Rufinamide—Anxiety—Levothyroxine—hypothyroidism	0.00185	0.022	CcSEcCtD
Rufinamide—CES1—liver—hypothyroidism	0.00178	0.00847	CbGeAlD
Rufinamide—SCN2A—cerebellum—hypothyroidism	0.00172	0.0082	CbGeAlD
Rufinamide—SCN3A—testis—hypothyroidism	0.00164	0.00781	CbGeAlD
Rufinamide—Insomnia—Levothyroxine—hypothyroidism	0.00161	0.0192	CcSEcCtD
Rufinamide—Insomnia—Dextrothyroxine—hypothyroidism	0.00161	0.0192	CcSEcCtD
Rufinamide—ALB—adrenal gland—hypothyroidism	0.00158	0.00753	CbGeAlD
Rufinamide—Fatigue—Dextrothyroxine—hypothyroidism	0.00154	0.0183	CcSEcCtD
Rufinamide—Fatigue—Levothyroxine—hypothyroidism	0.00154	0.0183	CcSEcCtD
Rufinamide—SCN3A—cerebellum—hypothyroidism	0.00152	0.00721	CbGeAlD
Rufinamide—Vision blurred—Liotrix—hypothyroidism	0.00152	0.018	CcSEcCtD
Rufinamide—Tremor—Liotrix—hypothyroidism	0.00151	0.0179	CcSEcCtD
Rufinamide—Agitation—Liotrix—hypothyroidism	0.00148	0.0176	CcSEcCtD
Rufinamide—Convulsion—Liotrix—hypothyroidism	0.00139	0.0165	CcSEcCtD
Rufinamide—Anxiety—Liotrix—hypothyroidism	0.00136	0.0162	CcSEcCtD
Rufinamide—ALB—testis—hypothyroidism	0.00131	0.00623	CbGeAlD
Rufinamide—Infection—Liotrix—hypothyroidism	0.0013	0.0155	CcSEcCtD
Rufinamide—Asthenia—Levothyroxine—hypothyroidism	0.00128	0.0152	CcSEcCtD
Rufinamide—Asthenia—Dextrothyroxine—hypothyroidism	0.00128	0.0152	CcSEcCtD
Rufinamide—Pruritus—Dextrothyroxine—hypothyroidism	0.00126	0.015	CcSEcCtD
Rufinamide—Pruritus—Levothyroxine—hypothyroidism	0.00126	0.015	CcSEcCtD
Rufinamide—Anorexia—Liotrix—hypothyroidism	0.00125	0.0149	CcSEcCtD
Rufinamide—ALB—liver—hypothyroidism	0.00124	0.00589	CbGeAlD
Rufinamide—Diarrhoea—Levothyroxine—hypothyroidism	0.00122	0.0145	CcSEcCtD
Rufinamide—Diarrhoea—Dextrothyroxine—hypothyroidism	0.00122	0.0145	CcSEcCtD
Rufinamide—Insomnia—Liotrix—hypothyroidism	0.00119	0.0141	CcSEcCtD
Rufinamide—CYP2E1—cardiovascular system—hypothyroidism	0.00118	0.00563	CbGeAlD
Rufinamide—Decreased appetite—Liotrix—hypothyroidism	0.00114	0.0135	CcSEcCtD
Rufinamide—Vomiting—Levothyroxine—hypothyroidism	0.00113	0.0135	CcSEcCtD
Rufinamide—Vomiting—Dextrothyroxine—hypothyroidism	0.00113	0.0135	CcSEcCtD
Rufinamide—Fatigue—Liotrix—hypothyroidism	0.00113	0.0134	CcSEcCtD
Rufinamide—Rash—Levothyroxine—hypothyroidism	0.00113	0.0134	CcSEcCtD
Rufinamide—Rash—Dextrothyroxine—hypothyroidism	0.00113	0.0134	CcSEcCtD
Rufinamide—Dermatitis—Levothyroxine—hypothyroidism	0.00112	0.0133	CcSEcCtD
Rufinamide—Dermatitis—Dextrothyroxine—hypothyroidism	0.00112	0.0133	CcSEcCtD
Rufinamide—Constipation—Liotrix—hypothyroidism	0.00112	0.0133	CcSEcCtD
Rufinamide—Headache—Dextrothyroxine—hypothyroidism	0.00112	0.0133	CcSEcCtD
Rufinamide—Headache—Levothyroxine—hypothyroidism	0.00112	0.0133	CcSEcCtD
Rufinamide—Nausea—Levothyroxine—hypothyroidism	0.00106	0.0126	CcSEcCtD
Rufinamide—Nausea—Dextrothyroxine—hypothyroidism	0.00106	0.0126	CcSEcCtD
Rufinamide—Hypersensitivity—Liotrix—hypothyroidism	0.000967	0.0115	CcSEcCtD
Rufinamide—Asthenia—Liotrix—hypothyroidism	0.000942	0.0112	CcSEcCtD
Rufinamide—CYP2E1—adrenal gland—hypothyroidism	0.000937	0.00446	CbGeAlD
Rufinamide—CYP2E1—blood—hypothyroidism	0.000937	0.00446	CbGeAlD
Rufinamide—Pruritus—Liotrix—hypothyroidism	0.000929	0.011	CcSEcCtD
Rufinamide—CYP2E1—thyroid gland—hypothyroidism	0.000904	0.0043	CbGeAlD
Rufinamide—Diarrhoea—Liotrix—hypothyroidism	0.000898	0.0107	CcSEcCtD
Rufinamide—Dizziness—Liotrix—hypothyroidism	0.000868	0.0103	CcSEcCtD
Rufinamide—Vomiting—Liotrix—hypothyroidism	0.000835	0.00991	CcSEcCtD
Rufinamide—Rash—Liotrix—hypothyroidism	0.000828	0.00983	CcSEcCtD
Rufinamide—Dermatitis—Liotrix—hypothyroidism	0.000827	0.00982	CcSEcCtD
Rufinamide—Headache—Liotrix—hypothyroidism	0.000822	0.00976	CcSEcCtD
Rufinamide—Nausea—Liotrix—hypothyroidism	0.00078	0.00926	CcSEcCtD
Rufinamide—CYP2E1—testis—hypothyroidism	0.000775	0.00369	CbGeAlD
Rufinamide—CYP3A4—blood—hypothyroidism	0.000754	0.00359	CbGeAlD
Rufinamide—CYP2E1—liver—hypothyroidism	0.000733	0.00348	CbGeAlD
Rufinamide—CYP2E1—cerebellum—hypothyroidism	0.000716	0.0034	CbGeAlD
Rufinamide—CYP3A4—liver—hypothyroidism	0.00059	0.0028	CbGeAlD
Rufinamide—SCN5A—Cardiac Progenitor Differentiation—NKX2-5—hypothyroidism	0.000307	0.0517	CbGpPWpGaD
Rufinamide—CES1—NRF2 pathway—SLC5A7—hypothyroidism	0.000241	0.0406	CbGpPWpGaD
Rufinamide—GRM5—G alpha (q) signalling events—TRH—hypothyroidism	0.00021	0.0353	CbGpPWpGaD
Rufinamide—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—hypothyroidism	0.000187	0.0316	CbGpPWpGaD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.000182	0.0306	CbGpPWpGaD
Rufinamide—ALB—Transport of organic anions—AVP—hypothyroidism	0.000147	0.0247	CbGpPWpGaD
Rufinamide—SCN7A—Axon guidance—CLTC—hypothyroidism	0.000139	0.0235	CbGpPWpGaD
Rufinamide—ALB—FOXA2 and FOXA3 transcription factor networks—NKX2-1—hypothyroidism	0.000127	0.0215	CbGpPWpGaD
Rufinamide—SCN11A—Axon guidance—CLTC—hypothyroidism	0.000124	0.0209	CbGpPWpGaD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.000117	0.0197	CbGpPWpGaD
Rufinamide—SCN8A—Axon guidance—CLTC—hypothyroidism	0.000114	0.0191	CbGpPWpGaD
Rufinamide—GRM5—G alpha (q) signalling events—AVP—hypothyroidism	0.00011	0.0186	CbGpPWpGaD
Rufinamide—GRM5—GPCR ligand binding—TRH—hypothyroidism	0.000106	0.0178	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—CLTC—hypothyroidism	9.94e-05	0.0167	CbGpPWpGaD
Rufinamide—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—hypothyroidism	9.85e-05	0.0166	CbGpPWpGaD
Rufinamide—CES1—NRF2 pathway—SLC5A5—hypothyroidism	9.63e-05	0.0162	CbGpPWpGaD
Rufinamide—GRM5—GPCR ligand binding—TSHB—hypothyroidism	9.42e-05	0.0159	CbGpPWpGaD
Rufinamide—GRM5—GPCR ligand binding—TSHR—hypothyroidism	9.42e-05	0.0159	CbGpPWpGaD
Rufinamide—SCN9A—Axon guidance—CLTC—hypothyroidism	9.18e-05	0.0155	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—CLTC—hypothyroidism	8.86e-05	0.0149	CbGpPWpGaD
Rufinamide—SCN3A—Axon guidance—CLTC—hypothyroidism	8.78e-05	0.0148	CbGpPWpGaD
Rufinamide—SCN2A—Axon guidance—CLTC—hypothyroidism	8.44e-05	0.0142	CbGpPWpGaD
Rufinamide—SCN4A—Axon guidance—CLTC—hypothyroidism	8.44e-05	0.0142	CbGpPWpGaD
Rufinamide—SCN10A—Axon guidance—CLTC—hypothyroidism	8.14e-05	0.0137	CbGpPWpGaD
Rufinamide—SCN1A—Axon guidance—CLTC—hypothyroidism	8.14e-05	0.0137	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—CLTC—hypothyroidism	8.1e-05	0.0137	CbGpPWpGaD
Rufinamide—SCN5A—Cardiac Progenitor Differentiation—IGF1—hypothyroidism	7.06e-05	0.0119	CbGpPWpGaD
Rufinamide—SCN7A—Axon guidance—VAV3—hypothyroidism	6.56e-05	0.0111	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—CLTC—hypothyroidism	6.55e-05	0.011	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—CLTC—hypothyroidism	6.27e-05	0.0106	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—CLTC—hypothyroidism	6.02e-05	0.0101	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—CLTC—hypothyroidism	6.02e-05	0.0101	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—TRH—hypothyroidism	5.97e-05	0.0101	CbGpPWpGaD
Rufinamide—SCN11A—Axon guidance—VAV3—hypothyroidism	5.85e-05	0.00986	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—CLTC—hypothyroidism	5.81e-05	0.00978	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—CLTC—hypothyroidism	5.81e-05	0.00978	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—CLTC—hypothyroidism	5.72e-05	0.00964	CbGpPWpGaD
Rufinamide—GRM5—GPCR ligand binding—AVP—hypothyroidism	5.55e-05	0.00936	CbGpPWpGaD
Rufinamide—ALB—Transport of vitamins, nucleosides, and related molecules—AVP—hypothyroidism	5.44e-05	0.00917	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—TRH—hypothyroidism	5.43e-05	0.00914	CbGpPWpGaD
Rufinamide—SCN8A—Axon guidance—VAV3—hypothyroidism	5.35e-05	0.00902	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—TSHR—hypothyroidism	5.32e-05	0.00897	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—TSHB—hypothyroidism	5.32e-05	0.00897	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—TSHB—hypothyroidism	4.84e-05	0.00815	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—TSHR—hypothyroidism	4.84e-05	0.00815	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—VAV3—hypothyroidism	4.68e-05	0.00789	CbGpPWpGaD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—AVP—hypothyroidism	4.66e-05	0.00785	CbGpPWpGaD
Rufinamide—SCN9A—Axon guidance—VAV3—hypothyroidism	4.33e-05	0.00729	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—VAV3—hypothyroidism	4.17e-05	0.00703	CbGpPWpGaD
Rufinamide—SCN3A—Axon guidance—VAV3—hypothyroidism	4.14e-05	0.00697	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—CLTC—hypothyroidism	4.08e-05	0.00688	CbGpPWpGaD
Rufinamide—SCN2A—Axon guidance—VAV3—hypothyroidism	3.98e-05	0.0067	CbGpPWpGaD
Rufinamide—SCN4A—Axon guidance—VAV3—hypothyroidism	3.98e-05	0.0067	CbGpPWpGaD
Rufinamide—SCN10A—Axon guidance—VAV3—hypothyroidism	3.83e-05	0.00646	CbGpPWpGaD
Rufinamide—SCN1A—Axon guidance—VAV3—hypothyroidism	3.83e-05	0.00646	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—VAV3—hypothyroidism	3.82e-05	0.00643	CbGpPWpGaD
Rufinamide—ALB—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	3.71e-05	0.00625	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CLTC—hypothyroidism	3.71e-05	0.00625	CbGpPWpGaD
Rufinamide—GRM5—GPCR ligand binding—POMC—hypothyroidism	3.69e-05	0.00622	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—VAV3—hypothyroidism	3.26e-05	0.00549	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—TRH—hypothyroidism	3.2e-05	0.0054	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—AVP—hypothyroidism	3.14e-05	0.00529	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—VAV3—hypothyroidism	3.09e-05	0.0052	CbGpPWpGaD
Rufinamide—ALB—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	3.08e-05	0.00518	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—VAV3—hypothyroidism	2.96e-05	0.00498	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—VAV3—hypothyroidism	2.95e-05	0.00498	CbGpPWpGaD
Rufinamide—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	2.92e-05	0.00492	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—TSHB—hypothyroidism	2.86e-05	0.00481	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—TSHR—hypothyroidism	2.86e-05	0.00481	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—AVP—hypothyroidism	2.85e-05	0.0048	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—VAV3—hypothyroidism	2.84e-05	0.00478	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—VAV3—hypothyroidism	2.84e-05	0.00478	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—VAV3—hypothyroidism	2.74e-05	0.00461	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—VAV3—hypothyroidism	2.74e-05	0.00461	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—VAV3—hypothyroidism	2.7e-05	0.00454	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—SH2B3—hypothyroidism	2.55e-05	0.00429	CbGpPWpGaD
Rufinamide—CYP2E1—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	2.37e-05	0.00399	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—POMC—hypothyroidism	2.09e-05	0.00351	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—VAV3—hypothyroidism	1.92e-05	0.00324	CbGpPWpGaD
Rufinamide—ALB—Platelet degranulation—IGF1—hypothyroidism	1.92e-05	0.00323	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—POMC—hypothyroidism	1.89e-05	0.00319	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—PRL—hypothyroidism	1.89e-05	0.00318	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	1.89e-05	0.00318	CbGpPWpGaD
Rufinamide—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—hypothyroidism	1.83e-05	0.00308	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—VAV3—hypothyroidism	1.75e-05	0.00294	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—AVP—hypothyroidism	1.68e-05	0.00284	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	1.56e-05	0.00263	CbGpPWpGaD
Rufinamide—ALB—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	1.48e-05	0.0025	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—IYD—hypothyroidism	1.48e-05	0.0025	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—VAV3—hypothyroidism	1.38e-05	0.00233	CbGpPWpGaD
Rufinamide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	1.35e-05	0.00228	CbGpPWpGaD
Rufinamide—ALB—Metabolism—IYD—hypothyroidism	1.27e-05	0.00215	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ATP5O—hypothyroidism	1.26e-05	0.00212	CbGpPWpGaD
Rufinamide—CYP2E1—Biological oxidations—POMC—hypothyroidism	1.26e-05	0.00212	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—TPO—hypothyroidism	1.19e-05	0.002	CbGpPWpGaD
Rufinamide—ALB—SLC-mediated transmembrane transport—AVP—hypothyroidism	1.17e-05	0.00197	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—POMC—hypothyroidism	1.12e-05	0.00189	CbGpPWpGaD
Rufinamide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	1.1e-05	0.00185	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ATP5O—hypothyroidism	1.08e-05	0.00183	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—IGF1—hypothyroidism	1.08e-05	0.00181	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—SH2B3—hypothyroidism	1.04e-05	0.00175	CbGpPWpGaD
Rufinamide—ALB—Metabolism—TPO—hypothyroidism	1.02e-05	0.00172	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	9.44e-06	0.00159	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	8.5e-06	0.00143	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	7.54e-06	0.00127	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—VAV3—hypothyroidism	7.12e-06	0.0012	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—IYD—hypothyroidism	6.88e-06	0.00116	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—AVP—hypothyroidism	5.94e-06	0.001	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ATP5O—hypothyroidism	5.85e-06	0.000986	CbGpPWpGaD
Rufinamide—CYP3A4—Biological oxidations—POMC—hypothyroidism	5.83e-06	0.000983	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—TPO—hypothyroidism	5.5e-06	0.000927	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—TSHB—hypothyroidism	5.49e-06	0.000925	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PIK3C2A—hypothyroidism	4.89e-06	0.000824	CbGpPWpGaD
Rufinamide—ALB—Metabolism—TSHB—hypothyroidism	4.72e-06	0.000795	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—IGF1—hypothyroidism	4.38e-06	0.000739	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PIK3C2A—hypothyroidism	4.2e-06	0.000708	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	4.15e-06	0.000699	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—SLC5A5—hypothyroidism	4.11e-06	0.000692	CbGpPWpGaD
Rufinamide—ALB—Metabolism—SLC5A5—hypothyroidism	3.53e-06	0.000595	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—TSHB—hypothyroidism	2.55e-06	0.000429	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	2.27e-06	0.000382	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—POMC—hypothyroidism	2.15e-06	0.000362	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—SLC5A5—hypothyroidism	1.91e-06	0.000321	CbGpPWpGaD
Rufinamide—ALB—Metabolism—POMC—hypothyroidism	1.85e-06	0.000311	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—POMC—hypothyroidism	9.97e-07	0.000168	CbGpPWpGaD
